<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.pharmaradar360.com/article/fda-recasts-drug-packaging-oversight-with-science-and-risk-based-container-closu-212514b16ec9a406</loc><news:news><news:publication><news:name>PharmaRadar360</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-05T14:29:22.000Z</news:publication_date><news:title>FDA Recasts Drug Packaging Oversight with Science- and Risk-Based Container Closure Guidance</news:title></news:news></url><url><loc>https://www.pharmaradar360.com/article/oric-stock-holds-steady-as-biotech-eyes-next-trial-and-earnings-0490ce6768597bd1</loc><news:news><news:publication><news:name>PharmaRadar360</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-05T14:15:17.000Z</news:publication_date><news:title>ORIC stock holds steady as biotech eyes next trial and earnings</news:title></news:news></url><url><loc>https://www.pharmaradar360.com/article/vrxa-jumps-as-traders-focus-on-biotech-breakout-setup-ffe5bbb195e962d9</loc><news:news><news:publication><news:name>PharmaRadar360</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-05T14:08:00.000Z</news:publication_date><news:title>VRXA Jumps As Traders Focus On Biotech Breakout Setup</news:title></news:news></url><url><loc>https://www.pharmaradar360.com/article/annovis-bio-stock-reacts-to-webinar-plan-and-steep-discount-to-analyst-targets-60ea8056814b23fb</loc><news:news><news:publication><news:name>PharmaRadar360</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-05T14:02:49.000Z</news:publication_date><news:title>Annovis Bio stock reacts to webinar plan and steep discount to analyst targets</news:title></news:news></url></urlset>